Article de Périodique
Sociodemographic and clinical characteristics of vapers using e-cigarettes exclusively: The French Vapoquid Study (2021)
Auteur(s) :
TRAN LUY, M. ;
AIRAGNES, G. ;
MATTA, J. ;
TOUBIANA, L. ;
ALLAGBE, I. ;
LIMOSIN, F. ;
LE FAOU, A. L.
Année :
2021
Page(s) :
2035-2043
Langue(s) :
Anglais
Domaine :
Tabac / Tobacco / e-cigarette
Discipline :
EPI (Epidémiologie / Epidemiology)
Thésaurus géographique
FRANCE
Thésaurus mots-clés
E-CIGARETTE
;
PROFIL SOCIO-DEMOGRAPHIQUE
;
ACCEPTABILITE
;
ENQUETE
;
SEVRAGE
;
SUBSTITUTS NICOTINIQUES
;
NICOTINE
Résumé :
Electronic cigarettes are increasingly being used as smoking cessation aids. Most studies assess the dual use of e-cigarettes and traditional cigarettes, but there remains a paucity of literature concerning individuals who use e-cigarettes exclusively.
Objective: The aim of this study is to examine the sociodemographic and clinical characteristics of exclusive e-cigarette users, and consider their willingness to quit e-cigarette use.
Methods: A French online survey was conducted from March to December 2017. We assessed the following factors: sociodemographic factors; the clinical characteristics of e-cigarette use and its social acceptability; and the self-perceived effectiveness of nicotine replacement therapy (NRT). Associations between the listed factors and a willingness to quit e-cigarette use were examined.
Results: A total of 386 exclusive e-cigarette users (70% men) participated in the study and were included in the analysis. Most respondents were not planning to quit e-cigarette use (75%). Compared to those who did not want to quit, a desire to quit was associated with using smoking cessation services (OR [95%CI]: 3.45 [1.82-6.56]), e-cigarette craving (OR [95%CI]: 2.63 [1.44-4.80]) and NRT past-use (1.78 [1.12-2.87]). Users who planned to quit expressed more concerns about smoking initiation among youths using e-cigarettes (OR [95%CI]: 3.62 [1.90-6.93]). In multivariate analysis, these associations remained significant for the use of smoking cessation services, e-cigarette cravings, and concerns about youth tobacco initiation.
Conclusion: Most exclusive e-cigarette users were not likely to quit. Planned cessation was associated with using smoking cessation services, experiencing e-cigarette dependence symptoms, and being concerned about smoking initiation among teenager e-cigarette users.
Objective: The aim of this study is to examine the sociodemographic and clinical characteristics of exclusive e-cigarette users, and consider their willingness to quit e-cigarette use.
Methods: A French online survey was conducted from March to December 2017. We assessed the following factors: sociodemographic factors; the clinical characteristics of e-cigarette use and its social acceptability; and the self-perceived effectiveness of nicotine replacement therapy (NRT). Associations between the listed factors and a willingness to quit e-cigarette use were examined.
Results: A total of 386 exclusive e-cigarette users (70% men) participated in the study and were included in the analysis. Most respondents were not planning to quit e-cigarette use (75%). Compared to those who did not want to quit, a desire to quit was associated with using smoking cessation services (OR [95%CI]: 3.45 [1.82-6.56]), e-cigarette craving (OR [95%CI]: 2.63 [1.44-4.80]) and NRT past-use (1.78 [1.12-2.87]). Users who planned to quit expressed more concerns about smoking initiation among youths using e-cigarettes (OR [95%CI]: 3.62 [1.90-6.93]). In multivariate analysis, these associations remained significant for the use of smoking cessation services, e-cigarette cravings, and concerns about youth tobacco initiation.
Conclusion: Most exclusive e-cigarette users were not likely to quit. Planned cessation was associated with using smoking cessation services, experiencing e-cigarette dependence symptoms, and being concerned about smoking initiation among teenager e-cigarette users.
Affiliation :
Centre Ambulatoire d'Addictologie, Département Médico-Universitaire de Psychiatrie et Addictologie, AP-HP.Centre-Université de Paris, Paris, France
UMS 011, Population-based Epidemiological Cohorts, Inserm, Villejuif, France
UMR_S 1142, LIMICS, IRSAN, Paris, France
UMR_S 1266, Centre Psychiatrie et Neurosciences, Inserm, Paris, France
Fédération Hospitalo-Universitaire Network of Research in Substance Use Disorder, Paris, France
UMS 011, Population-based Epidemiological Cohorts, Inserm, Villejuif, France
UMR_S 1142, LIMICS, IRSAN, Paris, France
UMR_S 1266, Centre Psychiatrie et Neurosciences, Inserm, Paris, France
Fédération Hospitalo-Universitaire Network of Research in Substance Use Disorder, Paris, France